LivingGLP1
Study S001338

The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients

Registration

Registration
NCT04839237
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE2
Masking
NONE
Status
WITHDRAWN
Enrollment
0
Start
2017-12-01
Primary completion
2020-12-01
Lead sponsor
Xiangya Hospital of Central South University
Conditions
Obesity
Interventions
DRUG:Liraglutide; DRUG:Liraglutide;metformin
Results posted
FALSE

Registered primary outcomes

  • Weight Change at 3 months [baseline and 3 months]
  • Genotype [baseline]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.